13 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $655M | -$136M | 74.5% | -23.5% | -$76M | $195M | $94M |
| 2024 | $605M | -$169M | 77.3% | -28.2% | -$69M | $97M | $164M |
| 2023 | $509M | -$207M | 74.8% | -45.7% | -$100M | $569M | $241M |
| 2022 | $538M | -$93M | 78.6% | -16.6% | $9M | $566M | $115M |
| 2021 | $535M | -$58M | 78.5% | -8.3% | $59M | $562M | $209M |
| 2020 | $494M | $20M | 78.5% | 6.1% | $84M | $430M | $235M |
| 2019 | $351M | -$7M | 74.8% | -0.3% | $16M | $149M | $177M |
| 2018 | $248M | -$64M | 67.7% | -13.6% | -$9M | $149M | $141M |
| 2017 | $177M | -$62M | 68.6% | -22.2% | -$41M | $97M | $79M |
| 2016 | $83M | -$132M | 44.2% | -139.1% | -$113M | $96M | $100M |
| 2015 | — | -$112M | — | — | — | $23M | $119M |
| 2014 | — | -$81M | — | — | — | $0 | $58M |
| 2013 | — | -$77M | — | — | — | — | $176M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $174M | -$71M | 77.6% | -38.7% | -$19M | — | $88M |
| Dec '25 | $174M | -$24M | 75.8% | -23.2% | -$23M | $195M | $94M |
| Sep '25 | $167M | -$37M | 73.2% | -21.5% | $15M | — | $342M |
| Jun '25 | $159M | -$40M | 73.9% | -24.9% | -$21M | — | $150M |
| Mar '25 | $155M | -$34M | 75.1% | -24.4% | -$46M | — | $127M |
| Dec '24 | $161M | -$66M | 79.2% | -39.3% | -$12M | $97M | $164M |
| Sep '24 | $155M | -$31M | 77.2% | -20.7% | -$307000 | — | $185M |
| Jun '24 | $150M | -$33M | 77.0% | -22.3% | -$13M | — | $165M |
| Mar '24 | $139M | -$39M | 75.7% | -30.0% | -$43M | $570M | $454M |
| Dec '23 | $134M | -$47M | 75.7% | -38.7% | -$21M | $569M | $241M |
| Sep '23 | $127M | -$49M | 74.8% | -45.7% | -$27M | $568M | $155M |
| Jun '23 | $126M | -$57M | 73.0% | -49.7% | -$30M | $567M | $157M |
| Mar '23 | $122M | -$53M | 75.8% | -49.3% | -$23M | $566M | $186M |
| Dec '22 | $128M | -$37M | 77.5% | -33.5% | -$10M | $566M | $115M |
| Sep '22 | $131M | -$27M | 77.3% | -18.8% | $17M | $565M | $244M |
| Jun '22 | $141M | -$24M | 79.8% | -15.0% | $12M | $564M | $367M |
| Mar '22 | $138M | -$5M | 79.8% | -0.6% | -$9M | $563M | $191M |
| Dec '21 | $133M | -$26M | 77.7% | -17.6% | $130000 | $562M | $209M |
| Sep '21 | $134M | -$13M | 77.4% | -6.4% | $21M | $561M | $690M |
| Jun '21 | $134M | -$15M | 78.6% | -9.2% | $24M | $561M | $349M |
How the market has priced NVCR against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Novocure Ltd's revenue has grown 5.8% per year. These are computed facts, not advice.
As of FY2025, Novocure Ltd reported $195M of total debt against $94M of cash; operating income covered interest expense -6.9×.
In FY2025, gross margin was 74.5%, operating margin -23.5%, and net margin -20.8%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.